These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15361509)

  • 41. Importance of the Australian Crohn's disease antibiotic study.
    Chamberlin W
    Gastroenterology; 2007 Nov; 133(5):1744-5; author reply 1745-6. PubMed ID: 17983827
    [No Abstract]   [Full Text] [Related]  

  • 42. Helicobacter pylori seroprevalence in Crohn's disease: lack of influence by pharmacological treatment.
    Guslandi M; Fanti L; Testoni PA
    Hepatogastroenterology; 2002; 49(47):1296-7. PubMed ID: 12239929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of antibiotics in Crohn's disease.
    Cangemi JR
    Dig Dis; 1999; 17(1):1-5. PubMed ID: 10436351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Etiology of Crohn's disease: Do certain food additives cause intestinal inflammation by molecular mimicry of mycobacterial lipids?
    Traunmüller F
    Med Hypotheses; 2005; 65(5):859-64. PubMed ID: 16043304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin.
    Prantera C; Lochs H; Campieri M; Scribano ML; Sturniolo GC; Castiglione F; Cottone M
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1117-25. PubMed ID: 16611272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dry eye syndrome and cataract as ocular manifestations of Crohn's disease.
    Mrugacz M; Sredzińska-Kita D; Cyrta-Jarocka E; Bakunowicz-Lazarczyk A
    Klin Oczna; 2005; 107(7-9):509-10. PubMed ID: 16417009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-mycobacterials and Crohn's disease.
    Chamberlin WM; Shafran I
    Aliment Pharmacol Ther; 2008 Aug; 28(3):373-4; author reply 374-5. PubMed ID: 19086334
    [No Abstract]   [Full Text] [Related]  

  • 48. European evidence based consensus on the diagnosis and management of Crohn's disease: current management.
    Travis SP; Stange EF; Lémann M; Oresland T; Chowers Y; Forbes A; D'Haens G; Kitis G; Cortot A; Prantera C; Marteau P; Colombel JF; Gionchetti P; Bouhnik Y; Tiret E; Kroesen J; Starlinger M; Mortensen NJ;
    Gut; 2006 Mar; 55 Suppl 1(Suppl 1):i16-35. PubMed ID: 16481629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease.
    Doherty GA; Bennett GC; Cheifetz AS; Moss AC
    Aliment Pharmacol Ther; 2010 Apr; 31(8):802-9. PubMed ID: 20055785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Lupus associated with ileocolitis following tuberculostatic treatment ( lupus and Crohn's disease )].
    Mornet P; Lafon J; de Mouilliac MV; Morin M
    Sem Hop; 1973 Jun; 49(30):2199-207. PubMed ID: 4354302
    [No Abstract]   [Full Text] [Related]  

  • 51. Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease.
    Maeda Y; Ng SC; Durdey P; Burt C; Torkington J; Rao PK; Mayberry J; Moshkovska T; Stone CD; Carapeti E; Vaizey CJ;
    Br J Surg; 2010 Sep; 97(9):1340-7. PubMed ID: 20632322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators].
    Martreau P
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1243-4. PubMed ID: 11277090
    [No Abstract]   [Full Text] [Related]  

  • 53. Mycobacterium paratuberculosis as a cause of Crohn's disease.
    McNees AL; Markesich D; Zayyani NR; Graham DY
    Expert Rev Gastroenterol Hepatol; 2015; 9(12):1523-34. PubMed ID: 26474349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary treatment of Crohn's disease: combined antibiotics taking center stage.
    Chamberlin W; Borody TJ; Campbell J
    Expert Rev Clin Immunol; 2011 Nov; 7(6):751-60. PubMed ID: 22014016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Australian Crohn's antibiotic study opens new horizons.
    Gitlin L; Biesecker J
    Gastroenterology; 2007 Nov; 133(5):1743-4; author reply 1745-6. PubMed ID: 17983826
    [No Abstract]   [Full Text] [Related]  

  • 56. Antibiotic use and the development of Crohn's disease: methodological issues.
    Schneider V; Suissa S
    Gut; 2004 Oct; 53(10):1544. PubMed ID: 15361509
    [No Abstract]   [Full Text] [Related]  

  • 57. Antibiotic use and the development of Crohn's disease.
    Card T; Logan RF; Rodrigues LC; Wheeler JG
    Gut; 2004 Feb; 53(2):246-50. PubMed ID: 14724158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Crohn disease caused by antibiotics? A medical hypothesis based on epidemiologic data].
    Demling L
    Fortschr Med; 1994 May; 112(14):195-6. PubMed ID: 8050759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease--a nationwide, register-based finnish case-control study.
    Virta L; Auvinen A; Helenius H; Huovinen P; Kolho KL
    Am J Epidemiol; 2012 Apr; 175(8):775-84. PubMed ID: 22366379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis.
    Ungaro R; Bernstein CN; Gearry R; Hviid A; Kolho KL; Kronman MP; Shaw S; Van Kruiningen H; Colombel JF; Atreja A
    Am J Gastroenterol; 2014 Nov; 109(11):1728-38. PubMed ID: 25223575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.